Roles of CD1d-restricted NKT cells in the intestine

Inflammatory Bowel Diseases

Volumn 13, Issue 9, 2007, Pages 1146-1152

  Van Dieren, Jolanda M ^a   Van Der Woude, C Janneke ^a   Kuipers, Ernst J ^a   Escher, Johanna C ^b   Samsom, Janneke N ^a   Blumberg, Richard S ^c   Nieuwenhuis, Edward E S ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cd1d; IBD; Lipid antigens; NKT cells

Indexed keywords

CD1D ANTIGEN; GAMMA INTERFERON; GLYCOLIPID; GLYCOSPHINGOLIPID; INTERLEUKIN 12; INTERLEUKIN 13; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANTIGEN PRESENTING CELL; CELL FUNCTION; CELL POPULATION; CYTOKINE PRODUCTION; ENTERITIS; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; INTESTINE MUCOSA; NATURAL KILLER T CELL; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ULCERATIVE COLITIS; UPREGULATION;

ANIMALS; ANTIGENS; ANTIGENS, CD1; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINES; KILLER CELLS, NATURAL; LIPIDS; LYMPHOCYTE ACTIVATION; MICE; MODELS, BIOLOGICAL; MUCOUS MEMBRANE;

EID: 34548653208     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20164     Document Type: Review

References (55)

1. Fuss IJ, Heller F, Boirivant M, et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest. 2004;113:1490-1497.
2. Saubermann LJ, Beck P, De Jong YP, et al. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology. 2000;119:119-128.
3. Stetson DB, Mohrs M, Reinhardt RL, et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med. 2003;198:1069-1076.
4. Godfrey DI, MacDonald HR, Kronenberg M, et al. NKT cells: what's in a name? Nat Rev Immunol. 2004;4:231-237.
5. Eberl G, Lees R, Smiley ST, et al. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol. 1999;162: 6410-6419.
6. Yu KO, Porcelli SA. The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. Immunol Lett. 2005;100: 42-55.
7. Balk SP, Ebert EC, Blumenthal RL, et al. Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes. Science. 1991;253:1411-1415.
8. Bleicher PA, Balk SP, Hagen SJ, et al. Expression of murine CD1 on gastrointestinal epithelium. Science. 1990;250:679-682.
9. Blumberg RS, Terhorst C, Bleicher P, et al. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J Immunol. 1991;147:2518-2524.
10. Exley M, Garcia J, Wilson SB, et al. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology. 2000;100:37-47.
11. Joyce S, Woods AS, Yewdell JW, et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science. 1998;279:1541-1544.
12. Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science. 1997; 278:1626-1629.
13. Kinjo Y, Wu D, Kim G, et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 2005;434:520-525.
14. Kinjo Y, Tupin E, Wu D, et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol. 2006;7:978-986.
15. Manner J, Debord KL, Ismail N, et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 2005;434:525-529.
16. Wu D, Xing GW, Poles MA, et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci U S A. 2005;102:1351-1356.
17. Zhou D, Mattner J, Cantu C III, et al. Lysosomal glycosphingolipid recognition by NKT cells. Science. 2004;306:1786-1789.
18. Bannai M, Kawamura T, Naito T, et al. Abundance of unconventional CD8(+) natural killer T cells in the large intestine. Eur J Immunol. 2001;31:3361-3369.
19. Heller F, Fuss IJ, Nieuwenhuis EE, et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 2002;17:629-638.
20. Iiai T, Watanabe H, Suda T, et al. CD161 + T (NT) cells exist predominantly in human intestinal epithelium as well as in liver. Clin Exp Immunol. 2002;129:92-98.
21. Ishimoto Y, Tomiyama-Miyaji C, Watanabe H, et al. Age-dependent variation in the proportion and number of intestinal lymphocyte subsets, especially natural killer T cells, double-positive CD4+ CD8+ cells and B220+ T cells, in mice. Immunology. 2004;113:371-377.
22. Matsuda JL, Naidenko OV, Gapin L, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med. 2000;192:741-754.
23. O'Keeffe J, Doherty DG, Kenna T, et al. Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer. Eur J Immunol. 2004;34:2110-2119.
24. Ohteki T, MacDonald HR. Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8-subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice. J Exp Med. 1994;180:699-704.
25. Balk SP, Burke S, Polischuk JE, et al. Beta 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium. Science. 1994;265:259-262.
26. van de Wal Y, Corazza N, Allez M, et al. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology. 2003;124:1420-1431.
27. Panja A, Blumberg RS, Balk SP, et al. CD1d is involved in T cell-intestinal epithelial cell interactions. J Exp Med. 1993;178:1115-1119.
28. Kita H, Naidenko OV, Kronenberg M, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology. 2002;123:1031-1043.
29. Metelitsa LS, Weinberg KI, Emanuel PD, et al. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells. Leukemia. 2003;17:1068-1077.
30. Nieuwenhuis EE, Matsumoto T, Exley M, et al. Cd1d-dependent regulation of bacterial colonization in the intestine. Gastroenterology. 130: A61. (abstract).
31. Berntman E, Rolf J, Johansson C, et al. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur J Immunol. 2005;35:2100-2109.
32. Nieuwenhuis EE, Matsumoto T, Exley M, et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med. 2002;8:588-593.
33. Ronet C, Darche S, Leite de MM, et al. NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. J Immunol. 2005;175:899-908.
34. Neurath MF, Fuss I, Kelsall BL, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med. 1995;182: 1281-1290.
35. Menachem Y, Trop S, Kolker O, et al. Adoptive transfer of NK 1.1+ lymphocytes in immune-mediated colitis: a pro-inflammatory or a tolerizing subgroup of cells? Microbes Infect. 2005;7:825-835.
36. Ueno Y, Tanaka S, Sumii M, et al. Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice. Inflamm Bowel Dis. 2005;11:35-41.
37. Zigmond E, Preston S, Pappo O, et al. Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphocyte plasticity in murine models of immune-mediated disorders. Gut. 2007;56:82-89.
38. Page MJ, Poritz LS, Tilberg AF, et al. Cd1d-restricted cellular lysis by peripheral blood lymphocytes: relevance to the inflammatory bowel diseases. J Surg Res. 2000;92:214-221.
39. Perera L, Shao L, Patel A, et al. Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm Bowel Dis. 2007;13: 298-307.
40. Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129:550-564.
41. Cui J, Shin T, Kawano T, et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 1997;278:1623-1626.
42. Dvorak AM, Dickersin GR. Crohn's disease: electron microscopic studies. Pathol Annu. 1979;14(Pt 2):259-306.
43. Marin ML, Greenstein AJ, Geller SA, et al. Freeze-fracture analysis of epithelial cell lysosomal inclusions in Crohn's disease. Ultrastruct Pathol. 1984;6:39-44.
44. Thyberg J, Graf W, Klingenstrom P. Intestinal fine structure in Crohn's disease. Lysosomal inclusions in epithelial cells and macrophages. Virchows Arch A Pathol Anat Histol. 1981;391:141-152.
45. Colgan SP, Morales VM, Madara JL, et al. IFN-gamma modulates CD1d surface expression on intestinal epithelia. Am J Physiol. 1996;271: C276-C283.
46. Colgan SP, Pitman RS, Nagaishi T, et al. Intestinal heat shock protein 110 regulates expression of CD1d on intestinal epithelial cells. J Clin Invest. 2003;112:745-754.
47. Nieuwenhuis EE, Gillessen S, Scheper RJ, et al. CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity. Exp Dermatol. 2005;14:250-258.
48. Natori T, Koezuka Y, Higa T. Agelasphins, novel α- galactosylceramides from the marine sponge Agelas Mauritianus. Tetrahedron Lett. 1993; 34:5591.
49. Traunmuller F. Etiology of Crohn's disease: do certain food additives cause intestinal inflammation by molecular mimicry of mycobacterial lipids? Med Hypotheses. 2005;65:859-864.
50. Prigozy TI, Naidenko O, Qasba P, et al. Glycolipid antigen processing for presentation by CD1d molecules. Science. 2001;291:664-667.
51. Rhodes JM, Gallimore R, Elias E, et al. Faecal mucus degrading glycosidases in ulcerative colitis and Crohn's disease. Gut. 1985;26:761-765.
52. Falk P, Hoskins LC, Larson G. Bacteria of the human intestinal microbiota produce glycosidases specific for lacto-series glycosphingolipids. J Biochem (Tokyo). 1990;108:466-474.
53. Larson G, Falk P, Hoskins LC. Degradation of human intestinal glycosphingolipids by extracellular glycosidases from mucin-degrading bacteria of the human fecal flora. J Biol Chem. 1988;263:10790-10798.
54. Sumida T, Sueyoshi N, Ito M. Utilization of ganglioside-degrading Paenibacillus sp. strain TS12 for production of glucosylceramide. Appl Environ Microbiol. 2002;68:5241-5248.
55. Yagi F, Eckhardt AE, Goldstein IJ. Glycosidases of Ehrlich ascites tumor cells and ascitic fluid - purification and substrate specificity of alpha-N-acetylgalactosaminidase and alpha-galactosidase: comparison with coffee bean alpha-galactosidase. Arch Biochem Biophys. 1990;280: 61-67.